https://www.has-sante.fr/jcms/p_3637595/fr/beclometasone/formoterol-eg-beclometasone-/-formoterol-asthme-et-bronchopneumopathie-chronique-obstructive-bpco 2025 France evaluation of the transparency committee Formoterol Fumarate asthma formoterol chronic obstructive lung disease, nos asthma asthma, nos pulmonary disease, chronic obstructive beclomethasone
--- https://www.ema.europa.eu/en/medicines/human/EPAR/trixeo-aerosphere 2021 false false false Netherlands French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug combinations drug approval europe budesonide budesonide glucocorticoids glucocorticoids bronchodilator agents bronchodilator agents formoterol, glycopyrronium bromide and budesonide formoterol formoterol adrenergic beta-2 receptor agonists adrenergic beta-2 receptor agonists muscarinic antagonists muscarinic antagonists pulmonary disease, chronic obstructive adult administration, inhalation drug interactions pregnancy breast feeding drug evaluation, preclinical Formoterol Fumarate Formoterol Fumarate glycopyrrolate glycopyrrolate